Biomedical Engineering Reference
In-Depth Information
distribution (APSD) metrics by full resolution and abbreviated Andersen Cascade Impactors
(ACIs): Part 2—Investigation of bias in extra-fi ne mass fraction with AIM-HRT impactor.
AAPS PharmSciTech 11(3):1115-1118
41. Chambers FE, Smurthwaite M (2012) Comparative performance evaluation of the Westech
Fine Particle Dose (FPD) impactor. In: Dalby RN, Byron PR, Peart J, Suman JD, Farr SJ,
Young PM (eds) Respiratory drug delivery-2012. Davis HealthCare International Publishing,
River Grove, IL, pp 553-558
42. Mitchell JP, Copley M, Sizer Y, Russell T, Solomon D (2012) Adapting the Abbreviated
Impactor Measurement (AIM) concept to make appropriate inhaler aerosol measurements to
compare with clinical data: a scoping study with the “Alberta” Idealized Throat (AIT) inlet.
J Aerosol Med Pulm Drug Deliv 25(4):188-197
43. Ehtezazi T, Saleem I, Shrubb I, Allanson ID, O'Callaghan C (2010) The interaction between
the oropharyngeal geometry and aerosols via pressurized metered dose inhalers. Pharm Res
27(1):175-186
44. Mitchell JP, Nagel MW, Avvakoumova V, MacKay H, Ali R (2009) The abbreviated impactor
measurement (AIM) concept: part 1—infl uence of particle bounce and re-entrainment—evalu-
ation with a “dry” pressurized metered dose inhaler (MDI)-based formulation. AAPS
PharmSciTech 10(1):243-251
45. Copley M, Mitchell J, Solomon D (2011) Evaluating the Alberta throat: an innovation to sup-
port the acquisition of more clinically applicable aerosol aerodynamic particle size distribution
(APSD) data in oral inhaled product (OIP) development. Inhalation 5(4):12-16
46. Roberts DL, Mitchell JP (2011) Infl uence of stage effi ciency curves on interpretation of
abbreviated impactor data. Drug delivery to the lungs-22, The Aerosol Society, Edinburgh,
UK, pp 177-180. Available at:
http://ddl-conference.org.uk/index.php?q=previous_confer-
ences
. Visited 4 Aug 2012
47. Dolovich MB, Mitchell JP (2004) Canadian Standards Association standard CAN/CSA/
Z264.1-02:2002: a new voluntary standard for spacers and holding chambers used with pres-
surized metered-dose inhalers. Can Respir J 11(7):489-495
48. Mitchell JP, Nagel M, Finlay B (2011) Advances in models for laboratory testing of inhalers:
there's more to it than meets the nose or mouth—The ADAM face models. In: Dalby RN,
Byron PR, Peart J, Suman JD, Farr SJ, Young PM (eds) Respiratory drug delivery Europe-2011.
Davis Healthcare International Publishing LLC, River Grove, IL, pp 457-461
49. European Directorate for the Quality of Medicines and Healthcare (EDQM). Preparations for
inhalation: aerodynamic assessment of fi ne particles. (2012) Section 2.9.18—European
Pharmacopeia, Council of Europe, 67075 Strasbourg, France
50. United States Pharmacopeial Convention (2012) USP 35-NF 30 Chapter 601: Aerosols, nasal
sprays, metered-dose inhalers and dry powder inhalers. Rockville, MD
51. Feddah MR, Brown KF, Gipps EM, Davies NM (2000)
In-vitro
characterisation of metered
dose inhaler versus dry powder inhaler glucocorticoid products: infl uence of inspiratory fl ow
rates. J Pharm Pharm Sci 3(3):317-324
52. Burnell PKP, Malton A, Reavill K, Ball MHE (1998) Design, validation and initial testing of
the Electronic Lung™ device. J Aerosol Sci 29(8):1011-1025
53. Hamilton M, Daniels G (2011) Assessment of early screening methodology using the Next
Generation and Fast Screen Impactor systems. Drug Delivery to the Lungs-22, The Aerosol
Society, Edinburgh, UK, 22:355-358. Available at:
http://ddl-conference.org.uk/index.
php?q=previous_conferences
. Visited 4 Aug 2012
54. Miller NC (2002) Apparatus and process for aerosol size measurement at varying gas fl ow
rates. US Patent 6,435,004-B1
55. Olson B, Berg E, Svensson M (2010) Comparing aerosol size distributions that penetrate
mouth-throat models under realistic inhalation conditions. In: Dalby RN, Byron PR, Peart J,
Suman JD, Farr SJ, Young PM (eds) Respiratory drug delivery-2010. Davis Healthcare
International Publishing, River Grove, IL, pp 225-234
Search WWH ::
Custom Search